One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents

por Coney, Joseph M, McCoy, Jasmyne E, Buxy Sinha, Samriddhi, Sonbolian, Nina, Zhou, Lujia, Hull, Thomas P, Lewis, Shawn A, Miller, David G, Novak, Michael A, Pendergast, Scott D, Pham, Hang, Platt, Sean M, Rao, Llewelyn J, Schartman, Jerome P, Singerman, Lawrence J, Donkor, Richard, Fink, Margaret, Zubricky, Ryan, Karcher, Helene
Publicado 2023